Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Med Virol ; 57(1): 36-46, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9890420

RESUMEN

Cells from a leiomyosarcoma tumor (LMS-1) from a patient with the acquired immunodeficiency syndrome (AIDS) were explanted, cultured in vitro, and studied by phase-contrast microscopy for morphologic and growth characteristics, immunostaining for cell markers, EBER in situ hybridization and polymerase chain reaction for detection of Epstein-Barr virus (EBV), and immunostaining for expression of EBV antigens. The cells exhibited very slow growth in vitro, with unusual elliptical and spindle-shaped morphology and fragmentation of the cytoplasm into long, tapering, cytoplasmic processes. Greater than 90% of cells expressed diffuse distribution of the smooth muscle isoform of actin by immunoperoxidase staining. Approximately 25% of cells expressed very bright fluorescence by immunostaining of the smooth muscle isoforms of calponin and actin. The majority of cells demonstrated a weak signal for CD21; approximately 5-10% of cells showed a strong signal that was confined to cell surfaces. The cultured cells harbored EBV, and infectious EBV continued to be detected by polymerase chain reaction and virus culture through several passages in vitro. Several EBV antigens were expressed, including latent antigen EBNA-1, immediate-early antigen BZLF1, early antigen EA-D, and late antigens, including viral capsid antigen p160, gp125, and membrane antigen gp350. Human umbilical cord lymphocytes that were transformed with virus isolated from cultured cells yielded immortalized cell lines that expressed EBV antigens similar to other EBV-transformed lymphocyte cell lines. These results confirm that EBV is capable of lytic infection of smooth muscle cells with expression of a repertoire of latent and replicative viral products and production of infectious virus. EBV infection of smooth muscle cells may contribute to the oncogenesis of leiomyosarcomas.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Infecciones por Herpesviridae/diagnóstico , Herpesvirus Humano 4/aislamiento & purificación , Leiomiosarcoma/virología , Músculo Liso/virología , Neoplasias de la Columna Vertebral/virología , Infecciones Tumorales por Virus/diagnóstico , Actinas/metabolismo , Adulto , Antígenos Virales/análisis , Biomarcadores/análisis , Proteínas de Unión al Calcio/metabolismo , Transformación Celular Viral , Proteínas de Unión al ADN/metabolismo , Antígenos Nucleares del Virus de Epstein-Barr/metabolismo , Femenino , Productos del Gen env/metabolismo , Infecciones por Herpesviridae/virología , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Leiomiosarcoma/patología , Linfocitos/virología , Proteínas de Microfilamentos , Microscopía de Contraste de Fase , Músculo Liso/patología , Reacción en Cadena de la Polimerasa , Precursores de Proteínas/metabolismo , Receptores de Complemento 3d/análisis , Neoplasias de la Columna Vertebral/patología , Transactivadores/metabolismo , Células Tumorales Cultivadas , Infecciones Tumorales por Virus/virología , Proteínas de la Matriz Viral/metabolismo , Proteínas Virales/metabolismo , Latencia del Virus , Replicación Viral , Productos del Gen env del Virus de la Inmunodeficiencia Humana , Calponinas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA